Figures computed from official regulatory filings — .
Statistical track record
FreeWin rates and median returns are available with a free account (5 insiders/month).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Details | |
|---|---|---|---|---|
Zenas BioPharma, Inc.Listing unverified | AwardD (derivative) | — | SEC | |
ARROWHEAD PHARMACEUTICALS, INC.Listing on record | Sell | $228.3K | SEC | |
Zenas BioPharma, Inc.Listing unverified | Buy | $70.2K | SEC | |
Zenas BioPharma, Inc.Listing unverified | Buy | $1.5M | SEC | |
Zenas BioPharma, Inc.Listing unverified | Buy | $584.7K | SEC | |
ARROWHEAD PHARMACEUTICALS, INC.Listing on record | Award | — | SEC | |
Zenas BioPharma, Inc.Listing unverified | Buy | $1M | SEC | |
Zenas BioPharma, Inc.Listing unverified | Buy | $5M | SEC | |
Zenas BioPharma, Inc.Listing unverified | AwardD (derivative) | — | SEC | |
Terns Pharmaceuticals, Inc.Listing unverified | AwardD (derivative) | — | SEC | |
Terns Pharmaceuticals, Inc.Listing unverified | AwardD (derivative) | — | SEC | |
ARROWHEAD PHARMACEUTICALS, INC.Listing on record | Award | $384.7K | SEC | |
ARROWHEAD PHARMACEUTICALS, INC.Listing on record | Gift | — | SEC | |
ARROWHEAD PHARMACEUTICALS, INC.Listing on record | Buy | $11.2K | SEC | |
ARROWHEAD PHARMACEUTICALS, INC.Listing on record | Buy | $4.1K | SEC | |
ARROWHEAD PHARMACEUTICALS, INC.Listing on record | Buy | $23.4K | SEC | |
ARROWHEAD PHARMACEUTICALS, INC.Listing on record | Buy | $11K | SEC | |
ARROWHEAD PHARMACEUTICALS, INC.Listing on record | Buy | $12.5K | SEC | |
Terns Pharmaceuticals, Inc.Listing unverified | Buy | $3M | SEC | |
Zenas BioPharma, Inc.Listing unverified | Buy | $1M | SEC | |
Terns Pharmaceuticals, Inc.Listing unverified | Buy | $2M | SEC | |
Zenas BioPharma, Inc.Listing unverified | AwardD (derivative) | — | SEC | |
Terns Pharmaceuticals, Inc.Listing unverified | AwardD (derivative) | — | SEC | |
Terns Pharmaceuticals, Inc.Listing unverified | AwardD (derivative) | — | SEC | |
ARROWHEAD PHARMACEUTICALS, INC.Listing on record | Buy | $27.5K | SEC |